The estimated Net Worth of Glenn S Boehnlein is at least 31.2 百万$ dollars as of 2 August 2024. Mr. Boehnlein owns over 20,000 units of Stryker stock worth over 1,044,830$ and over the last 9 years he sold SYK stock worth over 25,782,193$. In addition, he makes 4,375,730$ as Chief Financial Officer、 Vice President at Stryker.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Boehnlein SYK stock SEC Form 4 insiders trading
Glenn has made over 26 trades of the Stryker stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 20,000 units of SYK stock worth 6,660,000$ on 2 August 2024.
The largest trade he's ever made was exercising 60,005 units of Stryker stock on 11 January 2024 worth over 5,759,880$. On average, Glenn trades about 5,502 units every 66 days since 2016. As of 2 August 2024 he still owns at least 2,852 units of Stryker stock.
You can see the complete history of Mr. Boehnlein stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Glenn Boehnlein biography
Glenn S. Boehnlein serves as Chief Financial Officer, Vice President of the Company. He has global responsibilities for Finance activities, including Corporate Accounting, Reporting, Tax, Treasury and Internal Audit. Mr. Boehnlein began his career with us in 2003 as the Vice President of Finance and IT for our Endoscopy division and has taken on roles of increasing responsibility throughout his career, most recently as Group CFO of MedSurg and Neurotechnology. Prior to joining us, Mr. Boehnlein spent three years with Success TV as CFO. Prior to that, he was a partner and certified public accountant at Arthur Andersen. He received his bachelor’s and master’s degrees in accounting from Mississippi State University.
What is the salary of Glenn Boehnlein?
As the Chief Financial Officer、 Vice President of Stryker, the total compensation of Glenn Boehnlein at Stryker is 4,375,730$. There are 2 executives at Stryker getting paid more, with Kevin Lobo having the highest compensation of 14,974,800$.
How old is Glenn Boehnlein?
Glenn Boehnlein is 58, he's been the Chief Financial Officer、 Vice President of Stryker since 2016. There are 6 older and 16 younger executives at Stryker. The oldest executive at Stryker Corp. is Srikant Datar, 67, who is the Independent Director.
What's Glenn Boehnlein's mailing address?
Glenn's mailing address filed with the SEC is 2825, Airview Boulevard, Kalamazoo, Kalamazoo County, Michigan, 49002, United States.
Insiders trading at Stryker
Over the last 21 years, insiders at Stryker have traded over 2,226,515,535$ worth of Stryker stock and bought 219,711 units worth 9,400,673$ . The most active insiders traders include Ronda E Stryker、Pat Stryker、Jon L Stryker. On average, Stryker executives and independent directors trade stock every 6 days with the average trade being worth of 10,449,767$. The most recent stock trade was executed by Viju Menon on 27 August 2024, trading 600 units of SYK stock currently worth 213,000$.
What does Stryker do?
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.
What does Stryker's logo look like?
Complete history of Mr. Boehnlein stock trades at Inogen Inc、Stryker
Stryker executives and stock owners
Stryker executives and other stock owners filed with the SEC include:
-
Kevin Lobo,
Chairman of the Board, Chief Executive Officer -
timothy Scannell,
President, Chief Operating Officer -
Glenn Boehnlein,
Chief Financial Officer, Vice President -
Robert Fletcher,
Vice President, Chief Legal Officer -
Viju Menon,
Group President - Global Quality and Operations -
Kevin A. Lobo,
Chairman, CEO & Pres -
Timothy J. Scannell,
Pres & COO -
Glenn S. Boehnlein,
VP & CFO -
Viju S. Menon,
Group Pres of Global Quality & Operations -
Robert S. Fletcher,
VP & Chief Legal Officer -
Allan Golston,
Lead Independent Director -
Andrew Silvernail,
Independent Director -
Roch Doliveux,
Independent Director -
Sherilyn McCoy,
Independent Director -
Rajeev Suri,
Independent Director -
Ronda Stryker,
Independent Director -
Srikant Datar,
Independent Director -
Mary Brainerd,
Independent Director -
Preston Wells,
Vice President - Investor Relations -
Yin Becker,
Vice President - Communications, Public Affairs and Corporate Marketing -
William Berry,
Principal Accounting Officer, Vice President, Corporate Controller -
M. Kathryn Fink,
Chief Human Resource Officer, Vice President -
M. Kathryn Fink,
VP & Chief HR Officer -
William E. Berry Jr.,
VP & Chief Accounting Officer -
Dana S. McMahon,
VP & Chief Compliance Officer -
Alan Douville,
VP, Chief Information Officer & Chief Information Security Officer -
Robert C. Cohen,
CTO and VP of Global R&D - Joint Replacement -
Louise Francesconi,
Director -
David Floyd,
Group President, Orthopaedics -
Bijoy Sagar,
VP, Chief Information Officer -
Howard E Jr Cox,
Director -
Graham A Mc Lean,
President, Asia-Pacific -
Lonny J Carpenter,
Group President -
Michael Damon Hutchinson,
General Counsel -
Katherine Ann Owen,
VP, Strategy and IR -
William R Jellison,
VP and CFO -
Curtis E Hall,
VP, General Counsel -
Steven P Benscoter,
VP, Human Resources -
Howard L Lance,
Director -
Donald M Engelman,
Director -
Andrew Grant Fox Smith,
President -
Michael P Mogul,
Group President -
Tony M Mc Kinney,
V.P., CAO -
Stephen P Macmillan,
President and COO -
Marcia S Kaminsky,
V.P., Comms. & Public Affairs -
Michael W Rude,
VP of Human Resources -
Curt R Hartman,
V.P., Finance -
Ramesh Subrahmanian,
Group President, International -
Scott P Bruder,
VP, Chief Med&Scientific Off. -
Luciano Cattani,
V.P. -
James E Kemler,
Vice President -
Thomas R Winkel,
Vice Pesident -
John W Brown,
Chairman and CEO -
Jon L Stryker,
10% owner -
Pat Stryker,
10% owner -
Jerome H Grossman,
Director -
John S Lillard,
Director -
Dean H Bergy,
Vice President, CFO & Secretar -
James R Lawson,
Vice President -
Gerard Thomas,
10% owner -
Stephen Si Johnson,
Vice President -
Mason Elizebeth S Upjohn,
10% owner -
Edward B Lipes,
Vice President -
William U Parfet,
Director -
Tatum Lisa M Skeete,
Director -
Rachel Ruggeri,
Director -
Giovanni Caforio,
Director -
James Andrew Pierce,
Group President -
Spencer S Stiles,
Group President